We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
When the president of a cancer-fighting foundation implored government advisers to back the drug Tarceva as a treatment for pancreatic cancer, she didn't tell them its Long Island manufacturer had given thousands of dollars to her group. Read More
SciClone Pharmaceuticals, Inc. announced that it has acquired the exclusive rights in the United States and Canada to develop and commercialize RP101, a clinical-stage compound for the treatment of cancer. Read More
Sanofi Pasteur MSD has submitted data to the European Medicines Agency (EMEA) in an effort to add to the indications for its cervical cancer vaccine, Gardasil. Read More
Avastin may contribute to tracheoesophageal (TE) fistula formation in patients with limited-stage small-cell lung cancer, Genentech said in a letter to healthcare professionals. Read More
Amgen plans to announce results from an Aranesp small-cell lung cancer clinical trial when the firm reports first-quarter earnings April 23, the company said.
The FDA has released documents questioning a new prostate cancer drug’s efficacy days before an agency advisory committee meets to discuss the product.
Roche’s and Genentech’s stocks took a hit after the companies announced lower doses of their drug Avastin were as effective in treating lung cancer as higher doses.
Funding to provide cervical cancer vaccines to women in the developing world must be a priority, as the majority of the 250,000 women who died from the disease last year lived in those countries, U.N. health officials announced.
An article published in the New England Journal of Medicine found that most patients participating in cancer clinical trials do not worry about financial conflicts of interest among researchers.